EFPIA - NEWSLETTER

EFPIA Newsletter 09 November 2017

News

09 November 2017 09112017 EFPIA survey underlines the importance of action on medicines to prevent patients...

The survey highlighted that medicines used by patients across Europe have integrated supply chains, which include the...

Events

20 NOV 2017

09112017 FEAM European Biomedical Policy Forum workshop on “Use of data in cross-border... Brussels

A FEAM European Biomedical Policy Forum workshop

Learn more →

21 NOV 2017

19 July 2017 War on Cancer – a patient’s journey The HAC, London, UK

3rd annual conference organised by The Economist Events

Learn more →

Documents

Assessing the impact of proposals for a Supplementary Protection Certificate (SPC) Manufacturing... 27 October 2017 (Publications)

A study by QuintilesIMS

Health Collaboration Guide 2017 26 October 2017 (Publications)

Showcasing best practice collaborations between patient organisations and industry, but also local authorities, governments,...

Working together with patient groups 11 October 2017 (Publications)

A publication from the Patient Think Tank to provide guidance for collaboration

What we are reading

Stop using antibiotics in healthy animals to prevent the spread of antibiotic resistance 07 November 2017 (WHO)

Help wanted in the fight against AMR: World Pharma Association wants to see incentives – but... 06 November 2017 (IFPMA)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶